Funding for this research was provided by:
Translational Cancer Research Network, a translational cancer research centre programme funded by the Cancer Institute NSW
Received: 3 September 2020
Accepted: 10 November 2020
First Online: 21 November 2020
Ethics approval and consent to participate
: Ethical approval (No. 18/082) was obtained from the South Eastern Sydney Local Health District Human Research Ethics Committee on 7 August 2018. Informed written consent was obtained from all individual participants included in the study.
: Not applicable.